The Medicines Company to Host Investor Day on January 23, 2018
The event will be led by
Eugene Braunwald, M.D., Distinguished Hersey Professor of Medicine at Harvard Medical Schooland founding Chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group;
John J.P. Kastelein, M.D., Ph.D., Professor of Medicine and Chairman of the Department of Vascular Medicineat the Academic Medical Centerof the University of Amsterdam; and
Marc S. Sabatine M.D., M.P.H., Lewis Dexter, M.D., Distinguished Chair in Cardiovascular Medicine at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical Schooland Chairman of the TIMI Study Group.
Presentations and panel discussions will focus on inclisiran, its highly-differentiated value proposition and clinical and non-clinical development, manufacturing, regulatory and pre-commercial projects, as well as on the continuing, unmet medical and market needs in atherosclerotic cardiovascular disease.
The event will be broadcast live via webcast. To access the live webcast
and view the accompanying slide presentation, visit the “Investors -
Events/Presentations” section of
A replay of the webcast will be archived and available after the event for a limited period of time.
The in-person event is reserved for financial analysts and institutional investors and is by invitation only.
The Medicines Company
Meg Langan, 973-290-6319
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations